Effect of farnesol on planktonic and biofilm cells of Staphylococcus epidermidis by Gomes, F. I. et al.
Effect of Farnesol on Planktonic and Biofilm Cells
of Staphylococcus epidermidis
Fernanda I. A. Gomes Æ Pilar Teixeira Æ
Joana Azeredo Æ Rosa´rio Oliveira
Received: 11 December 2008 / Accepted: 27 March 2009 / Published online: 14 April 2009
 Springer Science+Business Media, LLC 2009
Abstract Staphylococcus epidermidis is now amongst
the most important pathogenic agents responsible for
bloodstream nosocomial infections and for biofilm forma-
tion on indwelling medical devices. Its increasing resis-
tance to common antibiotics is a challenge for the
development of new antimicrobial agents. Accordingly, the
goal of this study was to evaluate the effect of farnesol, a
natural sesquiterpenoid, on Staphylococcus epidermidis
planktonic and biofilm cells. Farnesol displayed a signifi-
cant inhibitory effect on planktonic cells. Small concen-
trations (100 lM) were sufficient to exhibit antibacterial
effect on these cells. In biofilm cells the effect of farnesol
was not so pronounced and it seems to be strongly
dependent on the cells metabolic activity and amount of
matrix. Interestingly, the effect of farnesol at 200 lM was
similar to the effect of vancomycin at peak serum con-
centration either in planktonic or biofilm cells. Overall, the
results indicate a potential antibacterial effect of farnesol
against S. epidermidis, and therefore the possible action of
this molecule on the prevention of S. epidermidis related
infections.
Introduction
Staphylococcus epidermidis and related coagulase-negative
staphylococci (CoNS) are now well established as major
nosocomial pathogens associated with infections of
indwelling medical devices [2, 3, 15]. This bacterium has
become the primary cause of nosocomial bloodstream
infections, also of the eye, ear, nose, and throat as well as
cardiovascular infections [15]. This is related, in part, to
the organism’s ability to adhere to surfaces and form bio-
films [2, 5, 10, 16]. In fact, the formation of biofilms has
been considered the main virulence mechanism of S. epi-
dermidis [10, 15], and is the main cause of chronic infec-
tions [5]. Biofilm formation requires the bacterial
attachment to solid surfaces, the development of bacterial
multilayers and their enclosing in a large exopolymeric
matrix [10]. This structure impairs the action of phagocytic
cells from the immune system and of antimicrobial agents
[5, 10, 16], and releases planktonic cells from the outer
layers, allowing the persistence of bacterial infections [10].
Biofilms are notoriously difficult to eradicate and are a
source of many recalcitrant infections [16]. However, a
more important consequence of biofilm formation, with
profound clinical implications is the markedly enhanced
resistance to antimicrobial agents by biofilm-associated
microorganisms, which are estimated to be 50–500 times
more resistant than their planktonic counterparts [6]. The
ability of biofilm-embedded cells to resist to antimicrobial
agents points to the importance of a continuous search for
novel agents that are effective against bacteria in this mode
of growth or that can work in synergy with the currently
available myriad of antimicrobial agents [6]. Several
studies have been assessing the antimicrobial potential of
natural terpene alcohols. Specifically, farnesol has been
reported to have antibacterial properties. For instance, in
Streptococcus mutans, brief exposure to farnesol affected
growth and metabolism by disrupting the bacterial mem-
brane, as well as the accumulation and polysaccharide
content of biofilms of the streptococci [6]. In Staphylo-
coccus aureus, farnesol was shown to inhibit biofilm
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formation and compromise cell membrane integrity [6].
Inoue et al. [4] also demonstrated that farnesol have anti-
bacterial activity against S. aureus. The results of these
authors suggested that farnesol might act on cell mem-
branes, where the damage to those membranes might be
one of the major modes of action of this terpene alcohol
[4].
Accordingly the goal of this study was to investigate the
effect of farnesol on planktonic and biofilm cells of S.
epidermidis.
Materials and Methods
Bacterial Strains and Growth Conditions
Four S. epidermidis strains were used in this study: two
good biofilm-producing (1457 and 9142) and the respective
mutants nonbiofilm-producing (1457-M10 and 9142-M10).
These strains are clinical isolates and were stored at or
below –120C in a liquid-nitrogen freezer and used as
needed. All strains were provided by Dr. G. B. Pier,
Channing Laboratory, Department of Medicine, Brigham
and Women’s Hospital, Harvard Medical School, Boston,
USA. Tryptic Soy Broth (TSB) and Tryptic Soy Agar
(TSA) were prepared according to the manufacturer’s
instructions. All strains were inoculated into 15 ml of TSB
from TSA plates not older than 2 days and grown for 24
(±2) h at 37C in an orbital shaker at 130 rpm. Cells were
harvested by centrifugation (for 5 min at 9500g and 4C),
and resuspended in TSB adjusted to an optical density
(640 nm) equivalent to 1 9 106 cells ml-1and then used in
the subsequent assays. Each stock solution of farnesol was
prepared in methanol. It was confirmed that methanol, at
the concentration used, had no effect on the growth of the
S. epidermidis strains studied.
Effect of Farnesol on Planktonic Cells
Farnesol Susceptibility of Planktonic Cells Assessed
by Alamar Blue Assay
Viability assays were performed in six well tissue-culture
plates (Sarstedt, Newton, NC, USA) containing 4 ml of a S.
epidermidis cell suspension (1 9 106 cells ml-1) in the
presence of farnesol (0, 30, 100, 150, 200, 250, and
300 lM; 0–66 lg ml-1) (Sigma). The suspensions were
incubated at 37C and at 130 rpm. After 6 and 12 h of
exposure to the different concentrations of farnesol, an
aliquot of 200 ll of S. epidermidis culture was removed
from all experimental and control wells and 20 ll (10% v/v
of culture volume) of Alamar Blue (AB) (Biosource), an
oxidation–reduction indicator, was added. Exposure of AB
to light was minimized throughout the experiment. The
plates were shaken gently and incubated for 1 h at 37C.
The growth was indicated by a change in colour from dark
blue to pink. The tolerance threshold was defined as the
lowest concentration of farnesol that prevented the devel-
opment of a pink colour. This experiment was repeated
twice, in triplicates.
Farnesol Susceptibility of Planktonic Cells Assessed by
CFU Plating
Colony forming units (CFU) were obtained from the same
wells used to obtain AB fluorescence as follows: 100 ll of
culture were removed from all experimental and control
wells and the viable cells were determined by performing
10-fold serial dilutions in saline blanks and plated in TSA.
Colonies were counted after 24 h at 37C. This experiment
was repeated twice, in triplicates.
Effect of Farnesol on Biofilm Cells
Farnesol Susceptibility of Biofilm Cells Assessed by Crystal
Violet and XTT Assays
In those assays only two S. epidermidis strains were used:
S. epidermidis 1457 and S. epidermidis 9142, both good
biofilm producers. Biofims were formed in 96 well tissue
culture plates (Sarstedt, Newton, NC, USA) containing
200 ll of a S. epidermidis cell suspension (1 9 106 cells
ml-1) in TSB supplemented with 0.25% of glucose per
well to promote biofilm formation. Plates were incubated at
37C with orbital shaking at 130 rpm for 24 h. At the end,
planktonic cells were removed carefully, and the biofilm
was washed twice with 200 ll of ultrapure water. The
biofilms were incubated in fresh nutrient medium con-
taining farnesol (0, 30, 100, 200, and 300 lM) (Sigma) and
CV and XTT assays were performed at time 4, 8, and 24 h.
A similar assay was carried out to assess the effect of van-
comycin at peak serum concentration (PS = 40 mg l-1) on
24 h biofilm cells. The aim of this assay was to compare
the effect of farnesol with the effect of the most common
‘‘last resort’’ antibiotic used to control nosocomial infec-
tions. Crystal violet was used as indicator of total biofilm
biomass. After exposure to farnesol and vancomycin, bio-
films were washed with 200 ll of 0.9% NaCl, then 250 ll
of methanol was added and allowed to act for 15 min.
Afterwards, methanol was removed and crystal violet was
added (5 min). The wells were washed with water and
finally, acetic acid 33% (v/v) was added. The absorbance
was measured at 570 nm.
Another colorimetric method based on the reduction of
XTT ({2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phe-
nylamino)carbonyl]-2H-tetrazolium hydroxide}) was
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applied to determine farnesol and vancomycin suscepti-
bility (XTT is converted to a coloured formazan salt in the
presence of metabolic activity) [8]. After exposure to
antimicrobial agents, biofilms were washed with 200 ll of
0.9% NaCl, then 250 ll of a solution containing
200 mg l-1 of XTT and 20 mg l-1 of PMS (phenazine
methosulphate) (Sigma) was added to each well. The
microtiter plates were incubated for 3 h at 37C in the dark.
The absorbance was measured at 490 nm.
Controls were biofilms not exposed to any antimicrobial
agent tested. All experiments were carried out in triplicate
and repeated three times.
Statistical Analysis
The data from all assays were compared using one-way
analysis of variance (ANOVA) by applying Tukey’s and
Bonferroni tests with all calculations carried out using
SPSS software (Statistical Package for the Social Sci-
ences). Differences achieving a confidence level of 95%
were considered significant.
Results and Discussion
Four S. epidermidis strains were selected for this study:
strain 1457 is a producer of the polysaccharide intercellular
adhesin (PIA), the major surface polysaccharide (poly-N-
acetyl glucosamine or simply PNAG) promoting coagu-
lase-negative staphylococci intercellular adherence and
biofilm formation, and its isogenic biofilm-negative mutant
icaA::Tn917 transductant 1457-M10 [11]; S. epidermidis
9142 another well-known producer of PIA and S. epide-
rmidis 9142-M10 an isogenic strain to 9142, containing a
transposon inserted into the ica locus which encodes the
biosynthetic enzymes for producing PIA/PNAG and thus
does not produce this molecule [2]. The growth inhibition
effect of farnesol on planktonic cells of S. epidermidis was
assessed using a rapid colorimetric assay that measures
cellular metabolic activity and is based on the reduction of
Alamar Blue. The viability assays showed, for all S. epi-
dermidis strains used, that incubation of planktonic cells in
the presence of 100 lM (22 lg ml-1) farnesol resulted in
no change in colour from blue to pink, indicating that this
concentration inhibited oxidation–reduction reactions in
the suspensions (data not shown). These data indicated that
low concentrations of farnesol were sufficient to exhibit
antibacterial effect, as was demonstrated by viability
assays. For Staphylococcus aureus this was observed in the
presence of 200 lM (44 lg ml-1) farnesol [6]. This
inhibitory effect can be due to the hydrophobic nature of
farnesol that favours its accumulation in the membrane,
possibly causing membrane disruption [6]. In fact, expo-
sure to terpene alcohols has been recently shown to affect
the cell membranes of S. aureus, Escherichia coli and
Listeria monocytogenes, resulting in leakage of K? ions
from cells [6].
Figure 1 depicts the effect of different farnesol con-
centrations on planktonic cells of the four strains studied.
Generally, there was a steep decrease in CFUs at 100 lM
of farnesol (P \ 0.05), levelling off for higher concentra-
tions. A farnesol concentration of 100 lM seems to be
sufficient to promote a very significant reduction in S.
epidermidis planktonic cells viability. It should be stressed
that for concentrations above 100 lM, the cellular viability
remains almost the same independently of farnesol con-
centration and exposure time. In fact, it seems that there is
a threshold of farnesol uptake acting as limiting factor
rather than farnesol concentration. Besides, bacterial pop-
ulations produce persister cells that neither grow nor die in
the presence of microbicidal agents. Persisters are largely
responsible for high levels of biofilm tolerance to antimi-
crobials [7]. This was also confirmed in experiments with
E. coli, where a small sub-population of cells remained
alive irrespective of the concentration of the antibiotic
(persisters) [9].
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Fig. 1 Effect of farnesol (0–300 lM) on S. epidermidis planktonic cells assessed by CFU enumeration, after 6 (a) and 12 h (b) of exposure to
farnesol. Bars represent standard deviation of the mean
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According to the other goal of this work, farnesol was
added to 24 h biofilms of S. epidermidis 1457 and 9142
strains and biofilm biomass and activity were evaluated.
These two strains were selected because they are both good
biofilm producers. As could be expected, biofilm cells were
much less sensitive to farnesol than their planktonic
counterparts. Noticeably, strain 9142 biofilm was more
sensitive to farnesol than the sessile cells of strain 1457
(Figs. 2 and 3). This corresponds to an inversion of the
observed behaviour for planktonic cells (Fig. 1). Those
facts prove that the biofilm structure along with the specific
physiology of the sessile mode of life determine a response
to antimicrobial agents, which cannot be extrapolated from
tests performed with planktonic cells.
To have some comparison of the response of biofilm
cells it was decided to assess the effectiveness of vanco-
mycin, one of the most frequently used antibiotics to treat
resistant nosocomial infections, which is primarily effec-
tive against coagulase negative Staphylococcus species
[12]. Furthermore, both tested agents act at the cell wall
level, vancomycin inhibits the biosynthesis of bacterial cell
wall, while farnesol is considered to disrupt the normal
barrier function of the cell membrane [1]. Interestingly,
farnesol at a concentration higher than 200 lM displayed
the same or higher effectiveness of vancomycin at peak
serum concentration (Figs. 2 and 3). In fact, the response of
the strains tested was very similar for both farnesol
([200 lM) and vancomycin. Accordingly, the biofilm of
strain 1457 showed higher tolerance to vancomycin than
the biofilm of strain 9142. In a previous study, Sousa et al.
[13] have shown that planktonic cells of strain 1457 dis-
played a higher glucose uptake, compared to 9142 plank-
tonic cells. Conversely, in biofilm form the glucose uptake
of strain 9142 was 3.5 times higher than that of sessile cells
of strain 1457. This suggests that cell susceptibility
increases with cell metabolic activity. Despite the effect of
specific changes in cell physiology triggered by the sessile
form of life, the higher amount of exopolysaccharides
present in the biofilm matrix of strain 1457 [14], can also
play a role in the increased tolerance to the antimicrobials
tested. This is another point in favour of the virulence
character of the matrix.
As conclusion, the results show the significant effect of
farnesol in the reduction of the viability of planktonic cells
of the four S. epidermidis strains assayed and less pro-
nounced on mature biofilm cells. In fact, on planktonic
cells, small concentrations of this sesquiterpenoid
(100 lM) are sufficient to exhibit antibacterial effect, as
was shown by viability assays. Additionally, the loss of
cellular viability and consequently the loss of biofilm for-
mation ability (main virulence factor) induced by farnesol
suggest a potential use of this molecule in the prevention of
S. epidermidis infection.
It was once again demonstrated that the response of
planktonic cells cannot be extrapolated for biofilm cells
and this must be a driving force for the development of new
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Fig. 2 Effect of farnesol (farn) (0–300 lM) and vancomycin (vanc) (40 mg l-1) on biofilm cells of S. epidermidis 1457 (a) and 9142 (b),
expressed as CV absorbance (total biofilm biomass)
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Fig. 3 Effect of farnesol (farn) (0–300 lM) and vancomycin (vanc) (40 mg l-1) on biofilm cells of S. epidermidis 1457 (a) and 9142 (b),
expressed as XTT absorbance (cellular activity)
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methodologies to assess sessile cells susceptibility to
antimicrobial agents.
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